{"id":"https://openalex.org/W2076942267","doi":"https://doi.org/10.1038/sj.bjc.6604402","title":"Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer","display_name":"Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer","publication_year":2008,"publication_date":"2008-05-27","ids":{"openalex":"https://openalex.org/W2076942267","doi":"https://doi.org/10.1038/sj.bjc.6604402","mag":"2076942267","pmid":"https://pubmed.ncbi.nlm.nih.gov/18506143","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2441954"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6604402","doi":"https://doi.org/10.1038/sj.bjc.6604402","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6604402","pdf_url":"https://www.nature.com/articles/6604402.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6604402.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074884529","display_name":"Natalie M. G. M. Appels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"N M G M Appels","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam 1066 EC, The Netherlands","Department of Pharmacy and Pharmacology, Slotervaart Hospital\u2014The Netherlands Cancer Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam 1066 EC, The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital\u2014The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066907718","display_name":"Maria J. Bolijn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M J Bolijn","raw_affiliation_strings":["The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands","The Netherlands Cancer Institute (Antoni van Leeuwenhoek Hospital) Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"The Netherlands Cancer Institute (Antoni van Leeuwenhoek Hospital) Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K Chan","raw_affiliation_strings":["AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK","AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110149948","display_name":"Trevor C. Stephens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T C Stephens","raw_affiliation_strings":["AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK","AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083046915","display_name":"G Hoctin-Boes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Hoctin-Boes","raw_affiliation_strings":["AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK","AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Middleton","raw_affiliation_strings":["Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, OX37L, Oxford, UK","Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, OX37L, Oxford, UK","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, UK","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J H Beijnen","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, PO Box 80082, Utrecht, 3508 TB, The Netherlands","Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, 1066 EC, The Netherlands","The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands","Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, Utrecht, The Netherlands","The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, PO Box 80082, Utrecht, 3508 TB, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, 1066 EC, The Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J S de Bono","raw_affiliation_strings":["Royal Marsden Hospital, Downs Road, Sutton, SM25PT, Surrey, UK","Royal Marsden Hospital Sutton UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital, Downs Road, Sutton, SM25PT, Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Royal Marsden Hospital Sutton UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079633934","display_name":"Adrian Llewellyn Harris","orcid":"https://orcid.org/0000-0003-1376-8409","observed_orcids":["https://orcid.org/0000-0003-1376-8409","https://orcid.org/0000-0002-5222-4765"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A L Harris","raw_affiliation_strings":["Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, OX37L, Oxford, UK","Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, OX37L, Oxford, UK","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, UK","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"J H M Schellens","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, PO Box 80082, Utrecht, 3508 TB, The Netherlands","The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands","Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, Utrecht, The Netherlands","The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, PO Box 80082, Utrecht, 3508 TB, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Division of Drug Toxicology, Department of Biomedical Analysis, Beta Faculty, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5000418012"],"corresponding_institution_ids":["https://openalex.org/I193662353","https://openalex.org/I2898336195"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":1.233,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.77357037,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"98","issue":"12","first_page":"1951","last_page":"1958"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.6523000001907349,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.6523000001907349,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.03060000017285347,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.8600000143051147},{"id":"https://openalex.org/keywords/prenyltransferase-inhibitors","display_name":"prenyltransferase inhibitors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7440000176429749},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8730000257492065},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9779999852180481},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7229999899864197},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7910000085830688},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.699999988079071},{"id":"https://openalex.org/keywords/ester-hydrolysis","display_name":"ester hydrolysis","score":0.6850000023841858},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6906984448432922},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6699846386909485},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.5868583917617798},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5698477029800415},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4720659554004669},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43901464343070984},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37993744015693665},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2787740230560303},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20837989449501038},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16629385948181152}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjc.6604402","doi":"https://doi.org/10.1038/sj.bjc.6604402","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6604402","pdf_url":"https://www.nature.com/articles/6604402.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2441954","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2441954","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:18506143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18506143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6604402","doi":"https://doi.org/10.1038/sj.bjc.6604402","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6604402","pdf_url":"https://www.nature.com/articles/6604402.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2076942267.pdf","grobid_xml":"https://content.openalex.org/works/W2076942267.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W2016806028","https://openalex.org/W2024210572","https://openalex.org/W2030907571","https://openalex.org/W2051626784","https://openalex.org/W2054022422","https://openalex.org/W2108247214","https://openalex.org/W2121495250","https://openalex.org/W2125244026","https://openalex.org/W2139248078","https://openalex.org/W2140135539","https://openalex.org/W2146472745","https://openalex.org/W2155167738","https://openalex.org/W2159594827","https://openalex.org/W2169705599","https://openalex.org/W2316903752","https://openalex.org/W2471433782","https://openalex.org/W4237568731","https://openalex.org/W4239576136"],"related_works":["https://openalex.org/W2276544302","https://openalex.org/W4252339394","https://openalex.org/W1994968074","https://openalex.org/W7104300143","https://openalex.org/W2787322057","https://openalex.org/W2137086876","https://openalex.org/W2146673033","https://openalex.org/W2019864526","https://openalex.org/W1967639975","https://openalex.org/W4400273997"],"abstract_inverted_index":{"AZD3409":[0,22,52,71,152,179],"is":[1,24,153],"an":[2,63],"orally":[3,55],"active":[4,20,129,207],"double":[5],"prodrug":[6,126],"that":[7,137,166],"was":[8,39,53,87,105,140,190],"developed":[9],"as":[10,89],"a":[11],"novel":[12],"dual":[13],"prenyltransferase":[14],"inhibitor.":[15],"The":[16,32,82,113],"formation":[17],"of":[18,34,50,84,124,160,187],"the":[19,42,94,103,125,128,167,185,195],"metabolite":[21,130],"acid":[23,180],"mediated":[25],"by":[26],"esterases":[27],"in":[28,93,157,202],"plasma":[29,181],"and":[30,48,102,111,119,127,155],"cells.":[31],"aim":[33],"this":[35],"phase":[36],"I":[37],"study":[38,193],"to":[40,56,109,175,197,210],"determine":[41],"maximum":[43],"tolerated":[44],"dose,":[45],"toxicities,":[46],"pharmacokinetics":[47],"pharmacodynamics":[49],"AZD3409.":[51],"administered":[54],"patients":[57,75],"with":[58,151,205],"advanced":[59],"solid":[60],"malignancies":[61],"using":[62],"interpatient":[64],"dose-escalation":[65],"scheme":[66],"starting":[67],"at":[68,78,142,172,178,183],"500":[69],"mg":[70,91],"once":[72],"daily.":[73],"Twenty-nine":[74],"were":[76,99,116],"treated":[77],"seven":[79],"dose":[80,132,144],"levels.":[81,145],"MTD":[83],"part":[85],"A":[86],"defined":[88],"750":[90],"b.i.d.":[92],"fasted":[95],"state.":[96],"Adverse":[97],"events":[98],"mainly":[100],"gastrointestinal":[101],"severity":[104],"on":[106],"average":[107],"mild":[108],"moderate":[110],"reversible.":[112],"dose-limiting":[114],"toxicities":[115],"vomiting,":[117],"diarrhoea":[118],"uncontrolled":[120],"nausea.":[121],"Pharmacokinetic":[122],"studies":[123,135,164,201],"indicated":[131],"proportionality.":[133],"Pharmacodynamic":[134,163],"showed":[136],"farnesyltransferase":[138],"(FTase)":[139],"inhibited":[141],"all":[143],"In":[146],"conclusion,":[147],"chronic":[148],"oral":[149],"dosing":[150,213],"feasible":[154],"results":[156],"significant":[158],"inhibition":[159],"FTase":[161,169],"activity.":[162],"revealed":[165],"maximal":[168],"inhibition,":[170],"estimated":[171],"49+/-11%,":[173],"appeared":[174],"be":[176],"reached":[177],"concentrations":[182],"which":[184],"occurrence":[186],"drug-related":[188],"toxicity":[189],"low.":[191],"This":[192],"supports":[194],"rationale":[196],"implement":[198],"biological":[199],"effect":[200],"clinical":[203],"trials":[204],"biologically":[206],"anticancer":[208],"drugs":[209],"define":[211],"optimal":[212],"regimens.":[214]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}